# The Human Medicines Regulations 2012, Paragraph 2


In this Part “cyanogenic substances” means preparations which—
(a) are presented for sale or supply under the name of, or as containing, amygdalin, laetrile or vitamin B17; or
(b) contain more than 0.1 per cent by weight of any substance having the formula either—
(i) alpha-Cyanobenzyl -6-O-Beta-d-glucopyranosyl -Beta-d-glucopyranoside, or
(ii) alpha-Cyanobenzyl -Beta-d-glucopyranosiduronic acid.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/1/paragraph/2 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-1/paragraph-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.